Tokyo, Sept. 23 -- National University Corporation - Hokkaido has issued a Notice of Procurement (Goods & Services) on Sep 22, 2025. Here are other related details:
Classification:
0004 Medical & Pharmaceutical Products
Summary:
⑴ Official in charge of disbursement of the procuring entity : HOUKIN Kiyohiro, President, The National University Corporation Hokkaido University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased : Atezolizumab (Genetical Recombination) (1200mg 20.0ml/vial) 33 vials
⑷ Delivery period : From 1 December, 2025 through 31 May, 2026
⑸ Delivery place : Hokkaido University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2025 in the Hokkaido area in Sales of products for participating in tenders by Single qualification for every ministry and agency, or in tenders by Hokkaido University,
B prove to have obtained the wholesale distribution license for selling pharmaceuticals in accordance with The Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
C prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the President,
D not be currently under a suspension of business order as instructed by the President, The National University Corporation Hokkaido University.
⑺ Time limit of tender : 17 : 00 12 November, 2025
⑻ Contact point for the notice : KOBAYASHI Yuuki, Medicine Section, Financial Division, Hokkaido University Hospital, Kita 14 Nishi 5 Kita-ku Sapporo-shi 060-8648 Japan, TEL 011-706-7405
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.
Disclaimer: Curated by HT Syndication.
